Product

AD-223B

Aliases

AD-223B Placebo

1 clinical trial

1 indication

Indication

Hypertension,Essential

Clinical trial

A Multicenter, Randomized, Double-blind, Active-control, Phase III Study to Evaluate the Efficacy and Safety of AD-223A and AD-223B Combination Therapy in Patients With Essential Hypertension

Status: Recruiting, Estimated PCD: 2025-02-01